99 Targeted complement inhibition using engineered bispecific antibodies that bind local antigens and endogenous complement regulators as a novel therapeutic approach

Immunobiology, vol. 228, pp. 152550

Authors 6

1. Leendert Adrianus Trouw Aachen

   Leiden University Medical Center

   Affiliation as printed

   Leiden University Medical Center, Leiden, Netherlands

2. Leoni Abendstein Aachen

   Leiden University Medical Center

   Affiliation as printed

   Leiden University Medical Center, Leiden, Netherlands

3. Kyra A. Gelderman

   Sanquin

   Affiliation as printed

   Sanquin Diagnostic Services, Amsterdam, Netherlands

4. Paul W.H.I. Parren

   Lava Therapeutics (Netherlands)

   Affiliation as printed

   Lava therapeutics, Utrecht, Netherlands

5. Thomas Harry Sharp Aachen

   Leiden University Medical Center

   Affiliation as printed

   Leiden University Medical Center, Leiden, Netherlands

6. Fleur S. van de Bovenkamp

   Lava Therapeutics (Netherlands)

   Affiliation as printed

   Lava therapeutics, Utrecht, Netherlands